Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Reliant: The Expensive Opportunities in Primary Care

Dec 01 2006

Related Content

Best Laid Plans: Pfizer's Torcetrapib Tanks

Dec 01 2006

The Acomplia Paradox: Primary Care Drug, Targeted Population

Dec 01 2006

Abbott Rides High After Torcetrapib Collapse: Is Everything Old New Again?

Dec 01 2006

Enzon: The Perils of Profitability

Apr 01 2004

Opportunity Cost: How Alkermes Plans to Survive the Long Winter

Sep 01 2002

Related Companies

Reliant Pharmaceuticals

Novartis AG

Pfizer Inc.

Abbott

Eli Lilly and Company

Alkermes plc

Ardea Biosciences, Inc.

Maxygen, Inc.

Astellas Pharma, Inc.

Abbott

BASF AG

Eurand N.V.

Ethypharm

Oscient Pharmaceuticals Corporation

Warner Chilcott PLC

Bausch Health Companies Inc.

Takeda Pharmaceutical Co. Ltd.

Takeda Pharmaceutical Co. Ltd.

Roche Holding AG

Merck & Co., Inc.

Sanofi

Additional Topics

Strategy BioPharmaceutical

More from Archive

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window